SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about recommendation of final dividend

27 May 2021 Evaluate

Strides Pharma Science has informed that the Board of Directors at their meeting held today on May 27, 2021, have recommended final dividend of Rs 2.50 per equity share of Rs 10 each for the financial year ended March 31, 2021. The dividend will be paid within 30 days from the date of shareholder’s approval at the ensuing Annual General Meeting of the Company.

The above information is a part of company’s filings submitted to BSE.


Strides Pharma Scien Share Price

1006.45 5.75 (0.57%)
20-Apr-2026 09:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.60
Dr. Reddys Lab 1232.65
Cipla 1242.10
Zydus Lifesciences 944.25
Lupin 2328.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×